---
$id: https://graph.org.ai/products/commodity/51262203
$type: Product
source: UNSPSC
code: "51262203"
title: "Spiroxatrine"
class: "51262200"
classTitle: "Adrenergic blocking agent dioxanes"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Spiroxatrine

**UNSPSC Code**: 51262203
**Class**: [Adrenergic blocking agent dioxanes](Adrenergic blocking agent dioxanes.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C22H25N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DR0QR50ALL, chemically known as 1,3,8-trianaspiro(4.5)decane-4-one,8-(1,4-benzodioxan-2-ylmethyl)-1-phenyl- but generally known as spiroxatrine, which bears US NIH Compound Identifier 5268. European Medicines Agency schedules Spiroxatrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10635MIG. The term SPIROXATRINE is an International Non-Proprietary Name. SPIROXATRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule spiroxatrine under HS 29349990 and SITC 51579. As of Q4 2014, SPIROXATRINE remains the US FDA Preferred Term for this commodity. Spiroxatrine bears US NLM identifiers UMLS ID C0075025 and NCI Concept Code C74108. SMILES: O=C1NCN(C21CCN(CC2)CC1OC2C(OC1)CCCC2)C1CCCCC1.

